A61K 38/12
Cyclic peptides
Official title: Cyclic peptides {, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C (A61K38/043 - A61K38/046 take precedence)}
A61K38/12 (Cyclic peptides) appears on 2,480 US grants and 4,540 published applications in this corpus.
Search patents in A61K- Granted patents
- 2,480
- Published applications
- 4,540
- Assignees
- 1,726
- Inventors
- 7,040
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 3 | 0 |
| 1988 | 1 | 0 |
| 1989 | 4 | 0 |
| 1990 | 5 | 0 |
| 1991 | 6 | 0 |
| 1992 | 4 | 0 |
| 1993 | 8 | 0 |
| 1994 | 15 | 0 |
| 1995 | 14 | 0 |
| 1996 | 25 | 0 |
| 1997 | 52 | 0 |
| 1998 | 64 | 0 |
| 1999 | 54 | 0 |
| 2000 | 39 | 0 |
| 2001 | 45 | 22 |
| 2002 | 36 | 57 |
| 2003 | 35 | 92 |
| 2004 | 33 | 102 |
| 2005 | 34 | 107 |
| 2006 | 38 | 119 |
| 2007 | 35 | 112 |
| 2008 | 39 | 106 |
| 2009 | 31 | 118 |
| 2010 | 51 | 166 |
| 2011 | 45 | 126 |
| 2012 | 48 | 158 |
| 2013 | 88 | 182 |
| 2014 | 117 | 237 |
| 2015 | 136 | 243 |
| 2016 | 127 | 274 |
| 2017 | 152 | 252 |
| 2018 | 141 | 208 |
| 2019 | 154 | 270 |
| 2020 | 153 | 253 |
| 2021 | 119 | 289 |
| 2022 | 122 | 295 |
| 2023 | 113 | 242 |
| 2024 | 109 | 170 |
| 2025 | 106 | 208 |
| 2026 | 76 | 132 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Combinatory treatment29 Sep 2026US 12,746,216 B2Arivin Therapeutics Oy
- Cyclic peptide compounds and methods of use29 Sep 2026US 12,746,269 B2
- Short conjugated oligoelectrolytesand antibiotics22 Sep 2026US 12,740,950 B2Nanyang Technological University
- Vitamin E and cancer therapeutic compositions and methods22 Sep 2026US 12,741,008 B2RS Oncology, LLC
- Use of high molecular weight hyaluronic acid as ocular transporting vehicle22 Sep 2026US 12,741,027 B2I. Com Medical GmbH
- Subcutaneous peptide delivery system8 Oct 2026US 2026/0306408 A1
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Vitamin e and cancer therapeutic compositions and methods8 Oct 2026US 2026/0306581 A1RS Oncology, LLC
- Water-soluble biomolecular glass microneedle and preparation method thereof1 Oct 2026US 2026/0294794 A1Institute of Process Engineering, Chinese Academy of Sciences
- Composition containing cyclic peptide compound and surfactant1 Oct 2026US 2026/0294806 A1Chugai Seiyaku Kabushiki Kaisha
Most cited
By later US patents
- Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents617US 6,294,192 B1Lipocine Inc. · 2001
- Engineered nucleic acids and methods of use thereof372US 8,822,663 B2Moderna Therapeutics, Inc. · 2014
- Methods for enhancing vascularization of implant devices356US 5,569,462 ABaxter International Inc. · 1996
- Compositions and methods for improved delivery of hydrophobic agents332US 6,451,339 B2Lipocine Inc. · 2002
- Pharmaceutical compositions containing an omega-3 fatty acid oil306US 6,284,268 B1Cyclosporine Therapeutics Limited · 2001